Filter posts

Ellmers' Cancer Bill Marks 100 Co-Sponsors

Today, Congresswoman Ellmers announced that 100 bipartisan cosponsors have signed on to support her bill …

Medicare Part B: Barriers to Cancer Treatment

The National Patient Advocate Foundation (PAF) has seen a notable rise in calls for assistance …

Reimbursement Cuts Jeopardize Public Health

Just this month physicians who administer lifesaving therapies in their offices are seeing their reimbursements …

Cancer Stem Cell Therapy: Real Or Just Hype?

Also known as tumor-initiating cells, cancer stem cells (CSC) have unique capability endemic to stem …

Childhood Cancer Groups Join Forces to Train Childhood Cancer Leaders

Cancer remains the leading cause of death by disease for children in the United States …

Cancer Research Pioneer Dr. Margaret Foti named 2012 Biotech Humanitarian Honoree

Today, BIO named Dr. Margaret Foti, , Ph.D., M.D. (h.c.), CEO of the American Association …

Meet 2011's Buzz of BIO Winner, Amrita Therapeutics

2011 Buzz of BIO Health Winner Amrita Therapeutics is a bio-pharma discovery company based in …

Oncology Clinical Trials - Secrets of Success

At last year’s BIO CEO & Investor Conference, BIO and BioMedTracker presented data showing that …

Developing Cancer Therapies and Diagnostics: 4 Pieces of Advice

Insights in to the molecular and genetic basis of disease are driving new product and …

BIO Investor Forum Company Snapshot: Immune Design

In the third installment of the Investor Forum Company Snapshots, hear from Immune Design Corp. …